 <h1>Tyvaso Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>treprostinil</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about treprostinil. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Tyvaso.</p><h2>In Summary</h2><p><b>Common side effects of Tyvaso include:</b> cough, headache, pharyngitis, flushing, and pharyngolaryngeal pain. <b>Other side effects include:</b> syncope.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to treprostinil: oral tablet extended release</i></p><p>Other dosage forms:</p><ul><li>inhalation solution</li><li>injection solution</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, treprostinil (the active ingredient contained in Tyvaso) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking treprostinil:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased urine</li>
<li>dry mouth</li>
<li>increased thirst</li>
<li>irregular heartbeat</li>
<li>muscle pain or cramps</li>
<li>nausea or vomiting</li>
<li>pain in the jaw, arms, or legs</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking treprostinil:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>diarrhea</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>headache, severe</li>
<li>sweating</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of treprostinil may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach discomfort</li>
<li>diarrhea</li>
<li>feeling of warmth</li>
<li>headache</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to treprostinil: inhalation solution, injectable solution, oral tablet extended release</i></p><h3>General</h3><p>Oral tablets: The most frequently reported side effects were headache, diarrhea, nausea, and flushing.</p>
<p></p>
<p>Oral inhalation: The most frequently reported side effects were cough, headache, diarrhea, nausea, dizziness, throat irritation, pharyngolaryngeal pain, and flushing.</p>
<p></p>
<p>Parenteral: The most frequently reported side effects were subcutaneous infusion site pain and reaction, headache, diarrhea, nausea, jaw pain, vasodilation, edema, and hypotension.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Infusion site pain (up to 85%), infusion site reaction (up to 83%), Infusion site bleeding/bruising (33.5%)</p>
<p><b>Frequency not reported</b>: Induration, erythema, infusion site infection</p>
<p><b>Postmarketing reports</b>: Subcutaneous infusion site abscess<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 30%), nausea (up to 30%)</p>
<p><b>Common</b> (1% to 10%): Abdominal discomfort, rectal hemorrhage, melena, vomiting, abdominal pain, dyspepsia</p>
<p><b>Frequency not reported</b>: Gastrointestinal bleeding<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 63%)</p>
<p><b>Common</b> (1% to 10%): Syncope, paresthesia, dizziness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (15%), vasodilation (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Hypotension, tachycardia, palpitation, hypertension, heart failure, bradycardia, hemorrhage</p>
<p><b>Frequency not reported</b>: Systemic blood pressure decreased, pallor, right ventricular heart failure, supraventricular tachycardia, hematoma</p>
<p><b>Postmarketing reports</b>: Thrombophlebitis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (up to 83.1%), pruritus (up to 13.6%)</p>
<p><b>Common</b> (1% to 10%): Contact dermatitis, sweating, ecchymosis, cellulitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Skin ulcer</p>
<p><b>Postmarketing reports</b>: Angioedema, macular rash, popular rash<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain in extremity (14%), pain in jaw (up to 13.1%)</p>
<p><b>Common</b> (1% to 10%): Myalgia, back pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Neck pain, arthralgia, leg cramp, muscle pain</p>
<p><b>Postmarketing reports</b>: Bone pain, muscle spasm<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (54%), throat irritation/pharyngolaryngeal pain (25%)</p>
<p><b>Common</b> (1% to 10%): Hypoxia, epistaxis, pharyngitis, dyspnea, sinusitis, pulmonary hypertension, rhinitis, hemoptysis</p>
<p><b>Uncommon</b> (0.1% to 1%): Bronchitis</p>
<p><b>Frequency not reported</b>: Wheezing, pneumonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (11.9%)</p>
<p><b>Common</b> (1% to 10%): Edema, infection, flu syndrome, asthenia, overdose, chest pain, fever, peripheral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Viral infection, malaise</p>
<p><b>Frequency not reported</b>: Infection, fatigue, BUN decreased, LDH decreased, bilirubin decreased, swelling arm<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, anorexia, dehydration, gout<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p>
<p><b>Frequency not reported</b>: Bleeding, thrombocytopenia, WBC decreased, RBC decreased, hemoglobin decreased, hematocrit decreased, eosinophils increased, platelet count increased<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety, depression</p>
<p><b>Uncommon</b> (0.1% to 1%): Nervousness<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Orenitram (treprostinil)." United Therapeutics Corporation, Silver Spring, MD. </p><p id="ref_2">2. "Product Information. Remodulin (treprostinil)." United Therapeutics Corp, Silver Spring, MD. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. "Product Information. Tyvaso (treprostinil)." United Therapeutics Corporation, Silver Spring, MD. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Tyvaso (treprostinil)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>11 Reviews</li>
<li>Drug class: agents for pulmonary hypertension</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tyvaso &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Orenitram, Remodulin</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Pulmonary Hypertension</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to treprostinil: inhalation solution, injectable solution, oral tablet extended release</i></p><h3>General</h3><p>Oral tablets: The most frequently reported side effects were headache, diarrhea, nausea, and flushing.</p><p></p><p>Oral inhalation: The most frequently reported side effects were cough, headache, diarrhea, nausea, dizziness, throat irritation, pharyngolaryngeal pain, and flushing.</p><p></p><p>Parenteral: The most frequently reported side effects were subcutaneous infusion site pain and reaction, headache, diarrhea, nausea, jaw pain, vasodilation, edema, and hypotension.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Infusion site pain (up to 85%), infusion site reaction (up to 83%), Infusion site bleeding/bruising (33.5%)</p><p><b>Frequency not reported</b>: Induration, erythema, infusion site infection</p><p><b>Postmarketing reports</b>: Subcutaneous infusion site abscess<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 30%), nausea (up to 30%)</p><p><b>Common</b> (1% to 10%): Abdominal discomfort, rectal hemorrhage, melena, vomiting, abdominal pain, dyspepsia</p><p><b>Frequency not reported</b>: Gastrointestinal bleeding<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 63%)</p><p><b>Common</b> (1% to 10%): Syncope, paresthesia, dizziness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (15%), vasodilation (up to 11%)</p><p><b>Common</b> (1% to 10%): Hypotension, tachycardia, palpitation, hypertension, heart failure, bradycardia, hemorrhage</p><p><b>Frequency not reported</b>: Systemic blood pressure decreased, pallor, right ventricular heart failure, supraventricular tachycardia, hematoma</p><p><b>Postmarketing reports</b>: Thrombophlebitis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (up to 83.1%), pruritus (up to 13.6%)</p><p><b>Common</b> (1% to 10%): Contact dermatitis, sweating, ecchymosis, cellulitis</p><p><b>Uncommon</b> (0.1% to 1%): Skin ulcer</p><p><b>Postmarketing reports</b>: Angioedema, macular rash, popular rash<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain in extremity (14%), pain in jaw (up to 13.1%)</p><p><b>Common</b> (1% to 10%): Myalgia, back pain</p><p><b>Uncommon</b> (0.1% to 1%): Neck pain, arthralgia, leg cramp, muscle pain</p><p><b>Postmarketing reports</b>: Bone pain, muscle spasm<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (54%), throat irritation/pharyngolaryngeal pain (25%)</p><p><b>Common</b> (1% to 10%): Hypoxia, epistaxis, pharyngitis, dyspnea, sinusitis, pulmonary hypertension, rhinitis, hemoptysis</p><p><b>Uncommon</b> (0.1% to 1%): Bronchitis</p><p><b>Frequency not reported</b>: Wheezing, pneumonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (11.9%)</p><p><b>Common</b> (1% to 10%): Edema, infection, flu syndrome, asthenia, overdose, chest pain, fever, peripheral edema</p><p><b>Uncommon</b> (0.1% to 1%): Viral infection, malaise</p><p><b>Frequency not reported</b>: Infection, fatigue, BUN decreased, LDH decreased, bilirubin decreased, swelling arm<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, anorexia, dehydration, gout<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p><p><b>Frequency not reported</b>: Bleeding, thrombocytopenia, WBC decreased, RBC decreased, hemoglobin decreased, hematocrit decreased, eosinophils increased, platelet count increased<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety, depression</p><p><b>Uncommon</b> (0.1% to 1%): Nervousness<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Orenitram (treprostinil)." United Therapeutics Corporation, Silver Spring, MD. </p><p id="ref_2">2. "Product Information. Remodulin (treprostinil)." United Therapeutics Corp, Silver Spring, MD. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. "Product Information. Tyvaso (treprostinil)." United Therapeutics Corporation, Silver Spring, MD. </p><h2>More about Tyvaso (treprostinil)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>11 Reviews</li>
<li>Drug class: agents for pulmonary hypertension</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tyvaso &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Pulmonary Hypertension</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>